Fingerprint
Dive into the research topics of 'ABMT using high dose cyclophosphamide, cisplatin, BCNU (CPA/cDDP/BCNU) for patients with high risk breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
ABMT using high dose cyclophosphamide, cisplatin, BCNU (CPA/cDDP/BCNU) for patients with high risk breast cancer
Research output: Contribution to journal › Article › peer-review